Session Type
Meeting
Search Results for Heart Failure
Abstract Number: 69
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: Congestive heart failure (CHF) and pneumonia are amongst the leading causes of hospitalization in the United States. Although a growing number of hospitals use both teaching and nonteaching hospitalist services for patient care, the differences in clinical outcomes and efficiency between these two services is not clearly known. The aim of this study […]
Abstract Number: 73
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Coronary artery calcification (CAC) is a strong predictor of cardiovascular events. We aimed to evaluate the prognostic significance of CAC detected by chest CT scan (CT) in heart failure (HF) with preserved ejection fraction (HFpEF) patients (pts) in the absence of coronary artery disease history (CAD Hx). Methods: In this retrospective cohort, we queried […]
Abstract Number: 75
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Subclinical hypothyroidism (SCH) is underdiagnosed in patients with heart disease, however, there has been controversy surrounding whether it is a cardiovascular risk factor or not. To determine the prognostic significance of SCH in Heart Failure (HF) with Preserved Ejection Fraction (HFpEF) we followed a cohort of patients for 9 years. Methods: In this retrospective […]
Abstract Number: 77
SHM Converge 2024
Background: SGLT-2 inhibitors are one of the emerging drugs in heart failure. Several meta-analyses prove its effect in reducing the composite outcome of cardiovascular death/hospitalization for heart failure but it is unknown if they contain all the primary studies hence a need for a pooled analysis Methods: We performed an umbrella analysis and used the […]
Abstract Number: 96
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Heart failure is a common condition characterized by recurrent exacerbations. Medication and dietary nonadherence are associated with readmissions. Telling smokers their lung age significantly improves the likelihood of successful smoking cessation. We hypothesized that using hand-carried ultrasound (HCU) to share with patients their own images of inferior vena cava (IVC) measurements would serve as […]
Abstract Number: M9
SHM Converge 2022
Background: We compared 1) monthly rates of hospitalizations by disease severity and heart failure types, 2) measures of in-hospital care process, 3) and 30-day clinical outcomes of patients with acute decompensated heart failure (ADHF) hospitalized during COVID-19 pandemic with those admitted in pre-pandemic periods. Methods: Retrospective study of 8989 ADHF hospitalizations (6769 unique patients, mean […]
Abstract Number: 111
SHM Converge 2024
Background: Inpatient admissions for Congestive Heart Failure (CHF) represent a substantial economic burden within the US healthcare system with patients experiencing high rates of 30-day readmission and mortality. To more efficiently and effectively serve complex cardiovascular (CV) patients at a major cardiac care center, Intermountain Health created a dedicated CV hospitalist service which has expanded […]
Abstract Number: 114
SHM Converge 2021
Background: Heart failure is expected to increase in prevalence globally.(1) The increased incidence of metabolic disorders coupled with the increase in life expectancy in Singapore has contributed to this trend. Heart failure poses a great burden on patients, caregivers and the healthcare system.Previous European studies have suggested that patients managed by internists differ in baseline […]
Abstract Number: 117
SHM Converge 2021
Background: Serum levels of pro-B-type natriuretic peptide (BNP) and N-terminal (NT) proBNP are measured at admission to assess likelihood of acutely decompensated heart failure (ADHF). Pro-BNP, released by myocardium due to cardiac wall distention, is cleaved into the active BNP and inactive NT-proBNP forms. Elevated NT-proBNP levels on initial presentation are a reliable marker of […]
Abstract Number: 121
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Diuretic therapy is the mainstay of treatment for heart failure exacerbations but its optimal dosing strategy remains unclear. In 2011, the DOSE trial exhibited a trend toward improvement in patients’ global symptom assessments when utilizing a high-dose diuretic strategy, which used nearly 80mg intravenous furosemide three times daily in the first 72 hours on […]